Back
Black Diamond Therapeutics Stock Price Chart
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Sell
50
BDTX
Black Diamond Therapeutics
Last Price:
3.29
Seasonality Move:
21.63%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade- The current trend is relatively stagnant and BDTX is experiencing slight buying pressure.
Black Diamond Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.06 | Buy |
| 20-day SMA: | 3.14 | Buy |
| 50-day SMA: | 4.16 | Sell |
| 200-day SMA: | 4.9 | Sell |
| 8-day EMA: | 3.14 | Buy |
| 20-day EMA: | 3.27 | Buy |
| 50-day EMA: | 3.9 | Sell |
| 200-day EMA: | 4.45 | Sell |
Black Diamond Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.25 | Sell |
| Relative Strength Index (14 RSI): | 46.51 | Sell |
| Chaikin Money Flow: | 97277 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.97 - 3.49) | Buy |
| Bollinger Bands (100): | (3.69 - 5.91) | Sell |
Black Diamond Therapeutics Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Black Diamond Therapeutics Stock
Is Black Diamond Therapeutics Stock a Buy?
- Black Diamond Therapeutics share price is 3.29 while BDTX 8-day simple moving average is 3.06, which is a Buy signal.
- The stock price of BDTX is 3.29 while Black Diamond Therapeutics 20-day SMA is 3.14, which makes it a Buy.
- Black Diamond Therapeutics 50-day simple moving average is 4.16 while BDTX share price is 3.29, making it a Sell technically.
- BDTX stock price is 3.29 and Black Diamond Therapeutics 200-day simple moving average is 4.90, creating a Sell signal.
BDTX Technical Analysis vs Fundamental Analysis
Sell
50
Black Diamond Therapeutics (BDTX)
is a Sell
Is Black Diamond Therapeutics a Buy or a Sell?
-
Black Diamond Therapeutics stock is rated a Sell
The current Black Diamond Therapeutics [BDTX] share price is $3.29. The Score for BDTX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Black Diamond Therapeutics Stock Info
Market Cap:
186.17M
Price in USD:
3.29
Share Volume:
535.02K
Black Diamond Therapeutics 52-Week Range
52-Week High:
7.66
52-Week Low:
1.62
Sell
50
Black Diamond Therapeutics (BDTX)
is a Sell
Black Diamond Therapeutics Share Price Forecast
-
What is the Black Diamond Therapeutics stock price today?
The Black Diamond Therapeutics stock price is 3.29 USD today. -
Will BDTX stock go up or go down?
Black Diamond Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Black Diamond Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Black Diamond Therapeutics is overvalued.
Is Black Diamond Therapeutics Stock a Buy?
- Black Diamond Therapeutics share price is 3.29 while BDTX 8-day exponential moving average is 3.14, which is a Buy signal.
- The stock price of BDTX is 3.29 while Black Diamond Therapeutics 20-day EMA is 3.27, which makes it a Buy.
- Black Diamond Therapeutics 50-day exponential moving average is 3.90 while BDTX share price is 3.29, making it a Sell technically.
- BDTX stock price is 3.29 and Black Diamond Therapeutics 200-day simple moving average is 4.45, creating a Sell signal.
Fundamental Analysis of Black Diamond Therapeutics
Is Black Diamond Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.66 per share, and an increase next year of $0.02 per share.
Technical Analysis of Black Diamond Therapeutics
Should I short Black Diamond Therapeutics stock?
- BDTX Moving Average Covergence Divergence (MACD) indicator is -0.25, suggesting Black Diamond Therapeutics is a Sell
- Black Diamond Therapeutics Relative Strength Index (RSI) is 46.51, which suggest Black Diamond Therapeutics is oversold
- The Bollinger Bands (25) for Black Diamond Therapeutics is (2.97 - 3.49), which suggest Black Diamond Therapeutics is a Sell
- The Bollinger Bands (100) for Black Diamond Therapeutics is (3.69 - 5.91), which suggest Black Diamond Therapeutics is a Sell
* Black Diamond Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.